Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ciprofloxacin Patent Expiration

Ciprofloxacin is Used for treating ear infections and inflammation in both pediatric and adult patients. It was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Cipro on Dec 26, 1990. Other drugs containing Ciprofloxacin are Otiprio, Cipro In Dextrose 5% In Plastic Container, Cipro In Sodium Chloride 0.9% In Plastic Container. 14 different companies have introduced drugs containing Ciprofloxacin.


Ciprofloxacin Patents

Given below is the list of patents protecting Ciprofloxacin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Otiprio US11246863 Ciprofloxacin otic composition and kits and method for using same Nov 27, 2038 Alk Abello
Otiprio US11040004 Otic gel formulations for treating otitis externa Nov 12, 2037 Alk Abello
Otiprio US9220796 Sterilization of ciprofloxacin composition Jul 01, 2035 Alk Abello
Otiprio US8318817 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Apr 27, 2030 Alk Abello
Otiprio US9233068 Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders Dec 11, 2029 Alk Abello
Otiprio US11369566 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Apr 21, 2029 Alk Abello
Otiprio US9205048 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Apr 21, 2029 Alk Abello
Otiprio US9603796 Controlled release antimicrobial compositions and methods for the treatment of otic disorders Apr 21, 2029 Alk Abello
Cipro US5695784

(Pediatric)

 Flavor-masked pharmaceutical compositions Jun 09, 2015

(Expired)

 Bayer Hlthcare
Cipro US5695784 Flavor-masked pharmaceutical compositions Dec 09, 2014

(Expired)

 Bayer Hlthcare
Cipro US6136347

(Pediatric)

 Flavor-masked pharmaceutical compositions Jul 06, 2013

(Expired)

 Bayer Hlthcare
Cipro US6136347 Flavor-masked pharmaceutical compositions Jan 06, 2013

(Expired)

 Bayer Hlthcare



Ciprofloxacin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ciprofloxacin Generic API Manufacturers

Several generic applications have been filed for Ciprofloxacin. The first generic version for Ciprofloxacin was by Hospira Inc and was approved on Aug 28, 2006. And the latest generic version is by Chartwell Life Molecules Llc and was approved on Mar 5, 2014.

Given below is the list of companies who have filed for Ciprofloxacin generic, along with the locations of their manufacturing plants worldwide.


1. BAXTER HLTHCARE

Baxter Healthcare Corp has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML

injectable Discontinued INJECTION N/A Mar 18, 2008
400MG/200ML

injectable Discontinued INJECTION N/A Mar 18, 2008





2. BAXTER HLTHCARE CORP

Baxter Healthcare Corp has filed for 4 different strengths of generic version for Ciprofloxacin. Out of these 200mg/100ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, 400mg/200ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML

injectable Prescription INJECTION AP Mar 18, 2008
400MG/200ML

injectable Prescription INJECTION AP Mar 18, 2008
400MG/40ML (10MG/ML)

(reference standard)

injectable Prescription INJECTION AP Apr 29, 2008
200MG/20ML (10MG/ML)

(reference standard)

injectable Prescription INJECTION AP Apr 29, 2008





3. BEDFORD

Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Bedford.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML

injectable Discontinued INJECTION N/A Mar 18, 2008
400MG/200ML

injectable Discontinued INJECTION N/A Mar 18, 2008


Manufacturing Plant Locations
New

Bedford's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bedford as present at those locations.

Country City Firm Name
United States
Curryville Bedford Farm Bureau Cooperative
Bedford Bedford Research Foundation, Inc.
Shelbyville Bedford Cheese Store Inc





4. BEDFORD LABS

Bedford Laboratories has filed for 3 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Bedford Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006
400MG/40ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006
1200MG/120ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006





5. CHARTWELL

Chartwell Life Molecules Llc has filed for 2 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/5ML

for suspension Prescription ORAL AB Mar 5, 2014
250MG/5ML

for suspension Prescription ORAL AB Mar 5, 2014


Manufacturing Plant Locations
New

Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.

Country City Firm Name
United States
Congers Chartwell Life Sciences LLC
Carmel Chartwell Pharmaceuticals Carmel LLC
Richboro Chartwells Division of Compass Group / Commodities Locker
West Caldwell Chartwell Pharmaceuticals West Caldwell LLC
Congers Chartwell Pharmaceuticals LLC





6. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006
400MG/40ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006





7. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Ciprofloxacin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006
400MG/40ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Bensenville Fresenius Kabi USA LLC (FK USA)
Skokie Fresenius Kabi USA LLC
North Andover Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Melrose Park Fresenius Kabi USA, LLC
Lake Zurich Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC





8. HIKMA FARMACEUTICA

Hikma Farmaceutica (portugal) Sa has filed for 4 different strengths of generic version for Ciprofloxacin. Out of these 200mg/100ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5%, 400mg/200ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hikma Farmaceutica.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML

injectable Discontinued INJECTION N/A Apr 21, 2008
400MG/200ML

injectable Prescription INJECTION AP Nov 18, 2009
400MG/40ML (10MG/ML)

injectable Prescription INJECTION AP Dec 22, 2009
200MG/20ML (10MG/ML)

injectable Prescription INJECTION AP Dec 22, 2009


Manufacturing Plant Locations
New

Hikma Farmaceutica's manufacturing plants are situated in 1 country - Portugal. Given below are the details of these plant locations as well as the firm names of Hikma Farmaceutica as present at those locations.

Country City Firm Name
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.





9. HOSPIRA

Hospira Inc has filed for 4 different strengths of generic version for Ciprofloxacin. Out of these 200mg/100ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER, 400mg/200ml version comes by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
400MG/40ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006
200MG/20ML (10MG/ML)

injectable Discontinued INJECTION N/A Aug 28, 2006
200MG/100ML

(reference standard)

injectable Prescription INJECTION AP Mar 18, 2008
400MG/200ML

(reference standard)

injectable Prescription INJECTION AP Mar 18, 2008


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Lake Forest Hospira Inc
Clayton Hospira, Inc.
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Morgan Hill Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Rocky Mount Hospira, Inc.
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





10. INFORLIFE

Inforlife Sa has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Inforlife.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML

injectable Prescription INJECTION AP Mar 18, 2008
400MG/200ML

injectable Prescription INJECTION AP Mar 18, 2008


Manufacturing Plant Locations
New

Inforlife's manufacturing plants are situated in 1 country - Switzerland. Given below are the details of these plant locations as well as the firm names of Inforlife as present at those locations.

Country City Firm Name
Switzerland
Campascio InfoRLife SA





11. TEVA PHARMS

Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Ciprofloxacin. All of these versions come by the name CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Teva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/100ML

injectable Discontinued INJECTION N/A Mar 18, 2008
400MG/200ML

injectable Discontinued INJECTION N/A Mar 18, 2008